Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

@article{Franco2005GrowthHT,
  title={Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.},
  author={Celina Franco and John Brandberg and Lars Birger L{\"o}nn and Bj{\"o}rn Andersson and B. -{\AA} Bengtsson and Gudmundur Johannsson},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2005},
  volume={90 3},
  pages={1466-74}
}
Abdominal obesity is associated with blunted GH secretion and a cluster of cardiovascular risk factors that characterize the metabolic syndrome. GH treatment in abdominally obese men reduces visceral adipose tissue and has beneficial effects on the metabolic profile. There are no long-term data on the effects of GH treatment on postmenopausal women with abdominal obesity. Forty postmenopausal women with abdominal obesity participated in a randomized, double-blind, placebo-controlled, 12-month… CONTINUE READING
41 Citations
54 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Similar Papers

Loading similar papers…